Sjogren Syndrome
Immunology·MeSH: Sjogren's Syndrome
Prevalence
0.1 / 100K
2 drugs in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| VAY736 | Novartis AG (NVS) |
Phase 1(1)
| Drug | Company |
|---|---|
| vay736 | Novartis AG (NVS) |
Frequently asked questions
How many drugs are in development for Sjogren Syndrome?
BioSniper tracks 2 drugs in development for Sjogren Syndrome across 1 company.
How many clinical trials target Sjogren Syndrome?
There are 3 clinical trials targeting Sjogren Syndrome tracked by BioSniper.
What is the prevalence of Sjogren Syndrome?
The estimated prevalence of Sjogren Syndrome is approximately 0.1 per 100,000 population.
Deep-dive into Sjogren Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis